Umicore, a catalyst manufacturing company and Solvias, a technology provider have entered into a long term collaboration allowing quid pro quo access to each company’s respective asymmetric catalysis technologies. This collaboration makes available chiral ligands and chiral metal complexes at industry scale.
The collaboration to simplify the access and the industrial scale use of both the ligand and metal-ligand technologies for the Butiphane, Josiphos, Mandyphos, MeOBIPHEP, Taniaphos and Walphos ligand families.The ligands and respective licenses are made available by Solvias. The related chiral metal-ligand complexes and licenses are available through Umicore.
The collaboration allows both Umicore and Solvias to offer a customer friendly IP access, both for the ligands and metal-ligand complexes. Customers can now utilize either in-situ ligand technologies or employ ready-to-use chiral metal-ligand complexes in their processes. The collaboration to allow end users to optimize process economics due to reduced catalyst consumption.
The terms of the agreement underlines Umicore’s strategic focus on emerging applications for organometallic precious metals chemistry in general and in homogeneous catalyst technologies. Umicore Business Line Precious Metals Chemistry develops catalysts for metathesis applications and C-X coupling reactions, and provides solutions for precious metals separation and recovery for homogeneous catalysis processes, apart from chiral catalysts.